1. | 3doctors | |
2. | eviltaskmaster | |
3. | beachgirlxoxo | |
4. | oneltonfan | |
5. | missygayle |
1. | 3doctors | |
2. | eviltaskmaster | |
3. | beachgirlxoxo | |
4. | oneltonfan | |
5. | missygayle |
1. | beachgirlxoxo 01/29/2018 Goldman Sachs initiates as a sell, $32PT |
2. | oneltonfan 05/08/2018 Sees FY18 EPS of $1.19-1.21 |
3. | beachgirlxoxo 02/08/2018 Myriad's myRisk® Hereditary Cancer Test Finds More Than 12 Percent of Men with Prostate Cancer Carry an Inherited Genetic Mutation |
4. | 3doctors 05/08/2018 up 15.77%. |
5. | oneltonfan 05/08/2018 Yes ahah |
6. | beachgirlxoxo 06/21/2018 Top-Five National Payer Issues Positive Coverage Decision for Myriad's Prolaris® Test for Prostate Cancer |
7. | eviltaskmaster 05/08/2018 I am seeing $40s |
8. | beachgirlxoxo 02/06/2018 Beats EPS estimates by $0.07 and beats on revenues |
9. | beachgirlxoxo 01/15/2018 Awesome news |
10. | oneltonfan 02/21/2018 NCCN Guidelines Broadly Endorse Biomarker Testing in Prostate Cancer |